Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of pregabalin extended-release tablets for postherpetic neuralgia
CTR20243987Phase 3Completed
- Sponsor
- China Resources Double-Crane Pharmaceutical
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in postherpetic neuralgia (PHN), sponsored by China Resources Double-Crane Pharmaceutical. Started Dec 2024; status: completed.
02
Drugs
pregabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on CTR20243987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243987.